Vigil Neuroscience, Inc. (VIGL) Stock Analysis
DELISTED 2025
What happened to Vigil Neuroscience, Inc. (VIGL) stock?
Vigil Neuroscience, Inc. (VIGL) no longer trades on public markets. It was delisted in August 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- August 2025
- Last recorded price (historical):
- $8.05 (last quote on record before the August 2025 delisting; historical, not a current quote)
Market cap $376M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Vigil Neuroscience, Inc. (VIGL). Vigil Neuroscience, Inc. is a biotechnology company focused on developing microglia-targeted therapies for neurodegenerative diseases. Their lead candidate, VGL101, is in Phase I clinical trials.
Last analyzed: Mar 16, 2026Vigil Neuroscience, Inc. (VIGL) Healthcare & Pipeline Overview
More about this archive record
Can I still buy VIGL shares?
No. VIGL stopped trading on public markets in August 2025, so the shares are not available through a broker. Anything you see quoted for VIGL elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before VIGL stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Vigil Neuroscience, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.